Dear colleagues, There's still time to register for the Machine learning Model selection in NONMEM and NLME at the June Page meeting. Link below:
https://www.certarauniversity.com/store/4230502-page2025-workshop-machine-learning-model-selection-in-nlme-nonmem-with-pirana-and-r Mark Mark Sale M.D. Vice President Integrated Drug Development mark.s...@certara.com Remote-Forestville CA Office Hours 9 AM - 5 PM Eastern Time +1 302-516-1684 www.certara.com [Certara Logo] From: owner-nmus...@globomaxnm.com <owner-nmus...@globomaxnm.com> On Behalf Of Iris Minichmayr Sent: Wednesday, April 16, 2025 11:49 AM To: nmusers@globomaxnm.com Subject: [NMusers] Open PhD position at the Medical University of Vienna Some people who received this message don't often get email from iris.minichm...@meduniwien.ac.at<mailto:iris.minichm...@meduniwien.ac.at>. Learn why this is important<https://aka.ms/LearnAboutSenderIdentification> CAUTION: This email originated from outside of Certara. Do not click links or open attachments unless you recognize the sender and know the content is safe. Dear NMusers, We have an open PhD position in Clinical Pharmacology and Pharmacometrics at the Medical University of Vienna, Austria. A detailed description of the role is available here: https://www.meduniwien.ac.at/web/en/karriere/offene-stellen/personalmitteilungsblatt-nr12/25/nr12-clinical-pharmacology-reference-number-757-1/24 Please feel free to forward this opportunity to motivated potential candidates and contact us if you have any questions. Best wishes, Iris _______________________________________________ Asst. Prof. Dr. Iris Minichmayr Clinical Pharmacometrics and Translational Pharmacology Department of Clinical Pharmacology Medical University Vienna Währinger Gürtel 18-20 1090 Vienna, Austria T: +43 (0)1 40400 29820 iris.minichm...@meduniwien.ac.at<mailto:anna.herd...@meduniwien.ac.at> www.meduniwien.ac.at<http://www.meduniwien.ac.at/> www.akhwien.at<http://www.akhwien.at/> This message (including any attachments) may contain confidential, proprietary, privileged and/or private information. The information is intended to be for the use of the individual or entity designated above. If you are not the intended recipient of this message, please notify the sender immediately, and delete the message and any attachments. Any disclosure, reproduction, distribution or other use of this message or any attachments by an individual or entity other than the intended recipient is prohibited.
